ICOS-Texas Biotechnology
1 clinical trials · Sponsor
◉ Watch ICOS-Texas Biotechnology
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy of Sitaxsentan in the Treatment of Pulmonary Arterial Hypertension (NCT00034307) | ICOS-Texas Biotechnology |
Track ICOS-Texas Biotechnology automatically
Every clearance here is in the API, with alerts when new ones post.